"Graft vs Leukemia Effect" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunological rejection of leukemia cells following bone marrow transplantation.
| Descriptor ID |
D020544
|
| MeSH Number(s) |
G12.875.402.320.320
|
| Concept/Terms |
Graft vs Leukemia Effect- Graft vs Leukemia Effect
- Graft-vs-Leukemia Response
- Graft-vs-Leukemia Responses
- Response, Graft-vs-Leukemia
- Responses, Graft-vs-Leukemia
- Graft vs Leukemia Response
- Graft-vs-Leukemia Effect
- Effect, Graft-vs-Leukemia
- Effects, Graft-vs-Leukemia
- Graft-vs-Leukemia Effects
|
Below are MeSH descriptors whose meaning is more general than "Graft vs Leukemia Effect".
Below are MeSH descriptors whose meaning is more specific than "Graft vs Leukemia Effect".
This graph shows the total number of publications written about "Graft vs Leukemia Effect" by people in this website by year, and whether "Graft vs Leukemia Effect" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Graft vs Leukemia Effect" by people in Profiles.
-
Kim HT, Shaughnessy CJ, Rai SC, Reynolds C, Ho VT, Cutler C, Koreth J, Gooptu M, Romee R, Nikiforow S, Armand P, Alyea EP, Antin JH, Wu CJ, Soiffer RJ, Ritz J, Brown JR. Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia. Blood Adv. 2020 09 08; 4(17):4113-4123.
-
Sauter CT, Bailey CP, Panis MM, Biswas CS, Budak-Alpdogan T, Durham A, Flomenberg N, Alpdogan O. Interleukin-15 administration increases graft-versus-tumor activity in recipients of haploidentical hematopoietic SCT. Bone Marrow Transplant. 2013 Sep; 48(9):1237-42.
-
Hsieh MH, Varadi G, Flomenberg N, Korngold R. Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk. Biol Blood Marrow Transplant. 2002; 8(6):303-15.
-
Spitzer TR, McAfee S, Sackstein R, Colby C, Toh HC, Multani P, Saidman S, Weyouth DW, Preffer F, Poliquin C, Foley A, Cox B, Andrews D, Sachs DH, Sykes M. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. Biol Blood Marrow Transplant. 2000; 6(3A):309-20.